HOME Press Releases Hemodynamic Monitoring Systems Market worth 1,143.7 Million USD by 2021



Hemodynamic Monitoring Systems Market worth 1,143.7 Million USD by 2021


The report "Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021", This report studies the global hemodynamic monitoring systems market during the forecast period of 2016 to 2021. This market is expected to reach USD 1,143.7 Million by 2021 from USD 925.2 Million in 2016, at a CAGR of 4.3%.

     Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 89 market data Tables and 41 Figures spread through 136 Pages and in-depth TOC on "Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021"
http://www.marketsandmarkets.com/Market-Reports/hemodynamic-monitoring-systems-market-21684146.html
Early buyers will receive 10% customization on reports.

Factors such as technological advancements, growth in the number of people suffering from hypertension, growing diabetes population, and rapid growth in the aging population are driving the growth of the hemodynamic monitoring systems market. Moreover, growth in aging population and the number of people suffering from diseases in populous countries such as India and China are expected to offer significant growth opportunities for players in the hemodynamic monitoring Systems market. However, risks associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis, are challenging the growth of the hemodynamic monitoring systems market.

In this report, the global hemodynamic monitoring systems market is segmented on the basis of product, type, end user, and region.

Based on products, the global hemodynamic monitoring systems market is segmented into systems and disposables. The disposables segment is estimated to account for the largest share of the global hemodynamic monitoring systems market in 2016, and is projected to grow at the highest CAGR in the forecast period.

Based on types, the global hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and Noninvasive hemodynamic monitoring systems. The invasive monitoring systems segment is estimated to account for the largest share of the global hemodynamic monitoring systems market in 2016. The large share of this segment can be attributed to the increasing utilization of invasive hemodynamic monitoring systems in both intensive care units (ICUs) and operating theaters (OTs) for monitoring of patients with critical illnesses and hemodynamic instability.

Based on end users, the global hemodynamic monitoring systems market is broadly segmented into hospitals, cath labs and home and ambulatory sites. The hospitals segment is estimated to account for the largest share of the global market in 2016. Additionally, this segment is projected to grow at the highest CAGR during the forecast period.

On the basis of regions, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is estimated to account for the largest share of the global hemodynamic monitoring systems market, followed by Asia-Pacific, Europe, and the RoW. The Asia-Pacific market is projected to grow at the highest CAGR and serve as a revenue pocket for companies offering hemodynamic monitoring systems.

In 2015, the hemodynamic monitoring systems market was dominated by Edwards Lifesciences Corporation (U.S.), PULSION Medical Systems SE (Germany), and LiDCO Group plc. (U.K.). These companies accounted for a combined market share of 70% in 2015. The other players operating in the hemodynamic monitoring systems market are Cheetah Medical Inc. (Israel), Deltex Medical Group plc. (U.K.), Hemo Sapiens, Inc. (U.S.), ICU Medical, Inc. (U.S.), Osypka Medical GmbH (Germany), Schwarzer Cardiotek GmbH (Germany), and Tensys Medical, Inc. (U.S.).

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&Ms flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports